Utidelone monotherapy suggesting clinical efficacy in heavily pretreated platinum-resistant high-grade serous ovarian cancer: a case report
Abstract Background Platinum-resistant ovarian cancer (OC) presents a significant therapeutic challenge with limited effective salvage options and dismal survival outcomes. Utidelone (UTD1), a novel synthetic epothilone B analogue that circumvents P-glycoprotein-mediated drug efflux, demonstrates pr...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SpringerOpen
2026-04-01
|
| Seri Bilgileri: | Bulletin of the National Research Centre |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s42269-026-01433-8 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|